Cargando…

Reply to Kapur, V. Is Pre-Exposure Prophylaxis a Cost-Effective Intervention to Avert Rabies Deaths among School-Aged Children in India? Comment on “Royal et al. A Cost-Effectiveness Analysis of Pre-Exposure Prophylaxis to Avert Rabies Deaths in School-Aged Children in India. Vaccines 2023, 11, 88”

Detalles Bibliográficos
Autores principales: Royal, Abhishek, John, Denny, Bharti, Omesh, Tanwar, Ritesh, Bhagat, Deepak Kumar, Padmawati, Retna Siwi, Chaudhary, Vishal, Umapathi, Reddicherla, Bhadola, Pradeep, Utarini, Adi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10141556/
https://www.ncbi.nlm.nih.gov/pubmed/37112719
http://dx.doi.org/10.3390/vaccines11040807
_version_ 1785033409814331392
author Royal, Abhishek
John, Denny
Bharti, Omesh
Tanwar, Ritesh
Bhagat, Deepak Kumar
Padmawati, Retna Siwi
Chaudhary, Vishal
Umapathi, Reddicherla
Bhadola, Pradeep
Utarini, Adi
author_facet Royal, Abhishek
John, Denny
Bharti, Omesh
Tanwar, Ritesh
Bhagat, Deepak Kumar
Padmawati, Retna Siwi
Chaudhary, Vishal
Umapathi, Reddicherla
Bhadola, Pradeep
Utarini, Adi
author_sort Royal, Abhishek
collection PubMed
description
format Online
Article
Text
id pubmed-10141556
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-101415562023-04-29 Reply to Kapur, V. Is Pre-Exposure Prophylaxis a Cost-Effective Intervention to Avert Rabies Deaths among School-Aged Children in India? Comment on “Royal et al. A Cost-Effectiveness Analysis of Pre-Exposure Prophylaxis to Avert Rabies Deaths in School-Aged Children in India. Vaccines 2023, 11, 88” Royal, Abhishek John, Denny Bharti, Omesh Tanwar, Ritesh Bhagat, Deepak Kumar Padmawati, Retna Siwi Chaudhary, Vishal Umapathi, Reddicherla Bhadola, Pradeep Utarini, Adi Vaccines (Basel) Reply MDPI 2023-04-06 /pmc/articles/PMC10141556/ /pubmed/37112719 http://dx.doi.org/10.3390/vaccines11040807 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Reply
Royal, Abhishek
John, Denny
Bharti, Omesh
Tanwar, Ritesh
Bhagat, Deepak Kumar
Padmawati, Retna Siwi
Chaudhary, Vishal
Umapathi, Reddicherla
Bhadola, Pradeep
Utarini, Adi
Reply to Kapur, V. Is Pre-Exposure Prophylaxis a Cost-Effective Intervention to Avert Rabies Deaths among School-Aged Children in India? Comment on “Royal et al. A Cost-Effectiveness Analysis of Pre-Exposure Prophylaxis to Avert Rabies Deaths in School-Aged Children in India. Vaccines 2023, 11, 88”
title Reply to Kapur, V. Is Pre-Exposure Prophylaxis a Cost-Effective Intervention to Avert Rabies Deaths among School-Aged Children in India? Comment on “Royal et al. A Cost-Effectiveness Analysis of Pre-Exposure Prophylaxis to Avert Rabies Deaths in School-Aged Children in India. Vaccines 2023, 11, 88”
title_full Reply to Kapur, V. Is Pre-Exposure Prophylaxis a Cost-Effective Intervention to Avert Rabies Deaths among School-Aged Children in India? Comment on “Royal et al. A Cost-Effectiveness Analysis of Pre-Exposure Prophylaxis to Avert Rabies Deaths in School-Aged Children in India. Vaccines 2023, 11, 88”
title_fullStr Reply to Kapur, V. Is Pre-Exposure Prophylaxis a Cost-Effective Intervention to Avert Rabies Deaths among School-Aged Children in India? Comment on “Royal et al. A Cost-Effectiveness Analysis of Pre-Exposure Prophylaxis to Avert Rabies Deaths in School-Aged Children in India. Vaccines 2023, 11, 88”
title_full_unstemmed Reply to Kapur, V. Is Pre-Exposure Prophylaxis a Cost-Effective Intervention to Avert Rabies Deaths among School-Aged Children in India? Comment on “Royal et al. A Cost-Effectiveness Analysis of Pre-Exposure Prophylaxis to Avert Rabies Deaths in School-Aged Children in India. Vaccines 2023, 11, 88”
title_short Reply to Kapur, V. Is Pre-Exposure Prophylaxis a Cost-Effective Intervention to Avert Rabies Deaths among School-Aged Children in India? Comment on “Royal et al. A Cost-Effectiveness Analysis of Pre-Exposure Prophylaxis to Avert Rabies Deaths in School-Aged Children in India. Vaccines 2023, 11, 88”
title_sort reply to kapur, v. is pre-exposure prophylaxis a cost-effective intervention to avert rabies deaths among school-aged children in india? comment on “royal et al. a cost-effectiveness analysis of pre-exposure prophylaxis to avert rabies deaths in school-aged children in india. vaccines 2023, 11, 88”
topic Reply
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10141556/
https://www.ncbi.nlm.nih.gov/pubmed/37112719
http://dx.doi.org/10.3390/vaccines11040807
work_keys_str_mv AT royalabhishek replytokapurvispreexposureprophylaxisacosteffectiveinterventiontoavertrabiesdeathsamongschoolagedchildreninindiacommentonroyaletalacosteffectivenessanalysisofpreexposureprophylaxistoavertrabiesdeathsinschoolagedchildreninindiavaccines20231188
AT johndenny replytokapurvispreexposureprophylaxisacosteffectiveinterventiontoavertrabiesdeathsamongschoolagedchildreninindiacommentonroyaletalacosteffectivenessanalysisofpreexposureprophylaxistoavertrabiesdeathsinschoolagedchildreninindiavaccines20231188
AT bhartiomesh replytokapurvispreexposureprophylaxisacosteffectiveinterventiontoavertrabiesdeathsamongschoolagedchildreninindiacommentonroyaletalacosteffectivenessanalysisofpreexposureprophylaxistoavertrabiesdeathsinschoolagedchildreninindiavaccines20231188
AT tanwarritesh replytokapurvispreexposureprophylaxisacosteffectiveinterventiontoavertrabiesdeathsamongschoolagedchildreninindiacommentonroyaletalacosteffectivenessanalysisofpreexposureprophylaxistoavertrabiesdeathsinschoolagedchildreninindiavaccines20231188
AT bhagatdeepakkumar replytokapurvispreexposureprophylaxisacosteffectiveinterventiontoavertrabiesdeathsamongschoolagedchildreninindiacommentonroyaletalacosteffectivenessanalysisofpreexposureprophylaxistoavertrabiesdeathsinschoolagedchildreninindiavaccines20231188
AT padmawatiretnasiwi replytokapurvispreexposureprophylaxisacosteffectiveinterventiontoavertrabiesdeathsamongschoolagedchildreninindiacommentonroyaletalacosteffectivenessanalysisofpreexposureprophylaxistoavertrabiesdeathsinschoolagedchildreninindiavaccines20231188
AT chaudharyvishal replytokapurvispreexposureprophylaxisacosteffectiveinterventiontoavertrabiesdeathsamongschoolagedchildreninindiacommentonroyaletalacosteffectivenessanalysisofpreexposureprophylaxistoavertrabiesdeathsinschoolagedchildreninindiavaccines20231188
AT umapathireddicherla replytokapurvispreexposureprophylaxisacosteffectiveinterventiontoavertrabiesdeathsamongschoolagedchildreninindiacommentonroyaletalacosteffectivenessanalysisofpreexposureprophylaxistoavertrabiesdeathsinschoolagedchildreninindiavaccines20231188
AT bhadolapradeep replytokapurvispreexposureprophylaxisacosteffectiveinterventiontoavertrabiesdeathsamongschoolagedchildreninindiacommentonroyaletalacosteffectivenessanalysisofpreexposureprophylaxistoavertrabiesdeathsinschoolagedchildreninindiavaccines20231188
AT utariniadi replytokapurvispreexposureprophylaxisacosteffectiveinterventiontoavertrabiesdeathsamongschoolagedchildreninindiacommentonroyaletalacosteffectivenessanalysisofpreexposureprophylaxistoavertrabiesdeathsinschoolagedchildreninindiavaccines20231188